Empagliflozin and linagliptin and Zoledronic Acid (Zometa)
Determining the interaction of Empagliflozin and linagliptin and Zoledronic Acid (Zometa) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Zoledronic Acid Injection
- Empagliflozin and linagliptin-Zoledronic Acid Injection Concentrate
- Empagliflozin and linagliptin-Zoledronic acid Intravenous
- Empagliflozin and linagliptin-Zoledronic Acid IV
- Empagliflozin and linagliptin-Zolgensma
- Empagliflozin and linagliptin-Zolinza
- Zoledronic Acid (Zometa)-Empagliflozin and metformin
- Zoledronic Acid (Zometa)-Empagliflozin and Metformin Extended-Release Tablets
- Zoledronic Acid (Zometa)-Empagliflozin and Metformin Tablets
- Zoledronic Acid (Zometa)-Empliciti
- Zoledronic Acid (Zometa)-Emsam
- Zoledronic Acid (Zometa)-Emsam Transdermal